PT

Philippe Tramoy

Quadrivium Fund at Seventure Partners

Greater Paris Metropolitan Region

Overview

Work Experience

SP

Seventure Partners

  • Partner, Quadrivium Fund

    2013 - Current

    Quadrivium is a DeepTech Fund financing start-up companies in the field of Digital technologies and Life sciences linked to twelve academic and university institutions: UPMC, Sorbonne University, University of Paris IV, National Museum of Natural History, IRCAM, ENSCI, University of Compiègne, CNRS, Institut Curie, Pierre Gilles de Gennes Foundation, Fondation Voir et Entendre or Paris Sciences et Lettres PSL University

C

CryoCapCell

  • Board Member

    2016

    CryoCapCell is a biotechnology company that develops and manufactures new products for sample preparation in the field of electron microscopy with a special focus on Correlative Light and Electron Microscopy (CLEM). CryoCapCell develops and markets technologies for high-pressure vitrification.

P

PEP-Therapy

  • Board Member

    2015

    PEP-Therapy is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevant intracellular protein-protein interactions, thus inhibiting specifically key mechanisms of diseases. PEP-Therapy exploits research of Inserm (the French National Institute of Health), Institut Curie (largest French research and hospital center dedicated to cancer research) and Pierre & Marie Curie Paris University (UPMC – leading French scientific and medical university).

AT

Aenitis Technologies

  • Board Member

    2015

    Spin off research laboratories of CNRS (National Centre for Scientific Research) and ESPCI (a major institution of higher education and internationally renowned research center, and a fertile ground of innovation for industry), Aenitis Technologies develops innovative approach to separation, handling and filtration of components in fluids through the use of ultrasonic acoustic forces.

SB

Scipio Bioscience

  • Board Member

    2017 - 2024

mT

myBrain Technologies

  • Board Member

    2017 - 2023

KE

Keen Eye Technologies

  • Board Member

    2016 - 2022

M

MilliDrop

  • Board Member

    2015 - 2021

D

DIABNEXT

  • Board Member

    2018 - 2021

h

horseCom

  • Board Member

    2015 - 2019

Education

Investments

Aenitis Technologies

Series Unknown

Total Funding:

Scipio Bioscience

Seed

Total Funding: $8M

Relevant Websites